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Abstract 
 
Background: Cancer is a major cause of death worldwide. Limitations of current cancer therapies necessitate the search for 
new anticancer drugs. Plants represent an immeasurable source of bioactive compounds for drug discovery. The objective 
of this study was to assess the anti-proliferative and antioxidant potential of four indigenous South African plants 
commonly used in traditional medicine. 
Materials and Methods: The anti-proliferative activity of the plant extracts were assessed by the 2,3-Bis-(2-Methoxy-4-
Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide (XTT) assay on A431; HaCat; HeLa; MCF-7 and UCT-Mel 1 cells 
and sulforhodamine-B (SRB) assay on HCT-116 and HCT-15 cell lines. Antioxidant activity was determined using the 2, 
2-diphenyl-1-picrylhydrazyl (DPPH), nitric oxide (NO) and superoxide scavenging assays.  
Results: Three of the plant extracts (Combretum mollefruit, Euclea crispa subsp. crispa leaves and stems and Sideroxylon 
inerme leaves and stems showed anti-proliferative activity on the A431 cells with IC50values ranging between 26.9 - 46.7 
µg/ml. The Euclea crispa subsp. crispa extract also showed anti-proliferative activity on the MCF-7 cell line (45.7 µg/ml). 
All of the plant extracts (Combretum molle leaves and fruit, Euclea crispa subsp. crispa leaves and stems, Sideroxylon 
inerme leaves and stems and Terminalia prunioides leaves and stems) showed DPPH scavenging activity with IC50 values 
ranging from 1.8 µg/ml to 11.5 µg/ml.  
Conclusion: These results indicate that the active extracts of Combretum molle, Euclea crispa subsp. Crispa and 
Sideroxylon inerme warrant further investigation to determine the mechanism of anti-proliferative activity against 
cancerous cells.   These plant extracts also show potential for further evaluation in the prevention and treatment of cancer.  
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Abbreviations: ATCC: American Type Culture Collection; CANSA: Cancer Association of South Africa; DMEM: 
Dulbecco’s Modified Eagles Medium; DMSO: Dimethyl sulfoxide; DNA: Deoxyribonucleic acid; DPPH: 2, 2-diphenyl-1-
picrylhydrazyl; EMEM: Eagle’s Minimum Essential Medium; FBS: Fetal Bovine Serum; IC50: Fifty percent inhibitory 
concentration; MD: Maryland; NaOH: Sodium hydroxide; NBT: Nitrotetrazolium Blue chloride; NCCS: National Centre 
for Cell Science; NCI: National Cancer Institute; NO: Nitric oxide; ROS: Reactive Oxygen Species; RSA: Republic of 
South Africa; SD: Standard deviation; SRB: sulforhodamine-B; USA: United States of America; WHO: World Health 
Organization; XTT: 2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide. 
 
Introduction 
 
Cancer is one of the major causes of death due to non-communicable diseases world- wide. 
In 2012 alone, cancer was identified as the causal agent of more than 8.2 million deaths.  In addition, the incidence and 
mortality rates have shown an increasing trend in Africa, Asia and Central and South America. According to the World 
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Health Organization report, seventy percent of cancer deaths have occurred in these countries (WHO, 2014). In South 
Africa, more than 100,000 cases are reported each year. The six most prevalent cancers found among South African men 
are prostate cancer, lung cancer, colorectal cancer, esophageal cancer, Kaposi sarcoma and cancers of which the site of 
origin within the body is not known. The six most prevalent cancers found among South African women are breast cancer, 
cervical cancer, colorectal cancer, Kaposi sarcoma, melanoma and cancers of which the site of origin within the body is not 
known (CANSA, 2013). 
Conventional cancer treatment involves various aspects to either treat the disease itself or  
the symptoms of the disease or both.  In general, surgical removal of cancerous tissue, radiotherapy and chemotherapy are 
employed for the treatment of cancers. Limitations of current therapies including adverse side effects and lowered efficacy 
due to drug resistance, which warrants the search for new drugs (NCI cancer treatment research, 2017). 
Many anticancer agents in use today, originate from natural resources such as animals, 
microorganisms and plants (Nobili et al., 2009). Herbal medicine forms a big part of many traditional medicine systems. 
The knowledge of these traditional medicine systems have provided key information for the discovery of anticancer agents 
from plants. Traditional medicine further forms a very important source of affordable and readily accessible health care 
system for most people in developing countries (Falkenberg et al., 2002). 
Antioxidants are compounds that scavenge reactive oxygen species (ROS). Since ROS  
can cause DNA damage, which can lead to cancer development; antioxidants are believed to possess chemopreventive 
abilities. Well known plant derived antioxidants include ‘quercetin’; ‘resveratrol’; ‘curcumin’ and ‘catechins’. Many 
epidemiology studies have shown that cancer incidence is low in countries with high levels of antioxidant rich plant 
consumption and as such employing antioxidants as a nutritional supplement might aid in cancer prevention (Borek, 1997; 
NCI, 2014). 
The plants (Combretum molle R. Br. Ex G. Don, Euclea crispa subsp. Crispa (Thunb.) 
Gürke, Sideroxylon inerme L. and Terminalia prunioides M.A. Lawson) selected for this study have been used traditionally 
as anticancer agents and the available data ascribed anticancer properties to the compounds isolated from these plants. 
Table 1 gives the traditional usage; compounds isolated and reported anticancer activity of the plants. 
 
Materials and methods 
Materials 
 
The A431, HeLa, and MCF-7 cell lines were obtained from American Type Tissue Collection (ATCC), MD, USA, 
whereas the HCT-116 and HCT-15 cell lines were obtained from NCCS Pune, India. Prof Davids, University of Cape 
Town, Cape Town, RSA, kindly donated the UCT-Mel 1 and HaCat cell lines. Foetal bovine serum (FBS) and antibiotics 
were purchased from Separations (Pty) Ltd. (Randburg, Johannesburg, RSA). The XTT cell proliferation kit II, 
sulforhodamine-B (SRB), DPPH, ascorbic acid, Griess reagent, sodium nitroprusside, Nitrotetrazolium Blue chloride 
(NBT), sodium hydroxide (NaOH), quercetin and all other materials were of analytical grade and were acquired from 
Sigma-Aldrich (Missouri, USA).  
 
Plant collection and identification 
 
All plant materials were collected during 2013 in Nelspruit, Mpumalanga. The plants were identified by the 
HGJW Schweickerdt Herbarium at the University of Pretoria and given herbarium specimen (PRU) numbers. Combretum 
molle R. Br. Ex G. Don leaves and fruit (PRU 120569), Euclea crispasubsp. Crispa (Thunb.) Gürke leaves, stems (PRU 
120536), Sideroxylon inerme L. leaves, stems (PRU 120537), and Terminalia prunioides M.A. Lawson leaves and stems 
(PRU 120508). 
 
Extraction of plants 
 
The dried aerial parts of the plant were mechanically ground to a fine powder. The powdered plant material of 
each plant was extracted with ethanol for 48h and thereafter for another 24h using fresh solvent. A Buchner funnel was 
used to filter the solutes and which was subsequently evaporated by a vacuum rotary evaporator. The percentage yield of 
the plant extracts were calculated for the formula: 
 
                                                              % Yield =       Extract weight (g)    X100 
                                                                                   Powdered weight (g) 
Cell culturing 
 
The human epidermoid carcinoma (A431), metastatic melanoma (UCT-Mel 1), colorectal carcinoma (HCT-116 
and HCT-15) and keratinocytes (HaCat) cell lines were maintained in culture flasks containing Dulbecco’s Modified Eagles 
Medium (DMEM). The human breast adenocarcinoma (MCF-7), and cervix adenocarcinoma (HeLa) cell lines were 
maintained in Eagle’s Minimum Essential Medium (EMEM). The complete media for all the cell lines were comprised of 
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the respective media supplemented with 10 % FBS and 1 % antibiotics. The antibiotic mixture consisted of 100 U/ml 
penicillin, 100 µg/ml streptomycin, and 250 µg/L fungizone. All of the cell lines were grown at standard growth conditions 
(37°C in a humidified incubator set at 5% CO2) and sub-cultured when they had reached 100 % confluence.  
 
Cell proliferation assay 
XTT cell proliferation kit II 
 
The anti-proliferative activity of the samples was measured by the XTT method using the Cell Proliferation Kit II 
(Sigma-Aldrich, Missouri, USA). The assay was performed according to the method by Zheng et al., 2001.1 × 104 cells 
were seeded (in 100 µl) in a 96-well microtiter plate and incubated for 24h at standard growth conditions to allow for cell 
attachment. The plant extracts were assessed at concentrations ranging from 3.1µg/ml – 400 µg/ml. The vehicle control 
wells were exposed to 2% DMSO.  Actinomycin D (concentrations ranging between 3.91×10-4 µg/ml - 0.05 µg/ml) was 
used as positive control. Plant extracts in medium without cells were used as blank colour controls. The microtiter plates 
were incubated for 72h. Subsequently, 50 µl of XTT reagent (0.3 mg/ml) was added and the plate was further incubated for 
another 2 h. A multi-well plate reader (BIO-TEK Power-Wave XS) was used to measure the absorbance of the colour 
complex at 490 nm with a reference wavelength set at 690 nm. 
 
Sulforhodamine-B assay (SRB) assay 
 
The anti-cancer activity was measured according to the method by Madhunapantula et al., 2008.  In brief,100 µl of 
HCT-116 and HCT-15 cells were plated in a 96-well plate at a density of 0.5 × 104 cells/ml. After 48h incubation at 
standard growth conditions, the cells were exposed to the extracts at concentrations ranging between 0-200 µg/mL for 72h.  
The SRB assay was performed as specified by Skehan et al., 1990 to determine the cell viability.  Experimentally, 
cells were fixed in 1/4th volume of cold 50% (w/v) TCA at 4˚C for 1 h.  Thereafter, the media was decanted and the wells 
washed with water (200 µl × 4 times) to remove any remaining TCA and serum proteins.  The plates were dried and then 
incubated with 100 µl 0.4 % SRB for 30 min to stain the cellular proteins.  Quick washing with 1 % acetic acid (200 µl× 4 
times) removed any unbound SRB while, the bound SRB was solubilized in 10.0mM Tris base solution (100 µl/well). A 
multimode plate reader was used to measure the absorbance at a wavelength of 490 nm.  
 
Antioxidant assays 
DPPH 
 
The DPPH scavenging activity of the extracts were measured following the method by Du Toit et al., 2001. The 
plant extracts and positive control, vitamin C, were evaluated at concentrations ranging from 0.78 μg/ml to 100 μg/ml. 
DPPH ethanolic solution (0.04 M) was added to each sample well, whereas distilled water was added to the negative color 
control wells. The plates were incubated at room temperature in the dark for 30 minutes. Following the incubation period, 
the absorbance was measured using a BIO-TEK Power-Wave XS multiplate reader at a wavelength of 515 nm.  
 
 
Nitric oxide 
 
The nitric oxide scavenging potential of the samples was determined by utilizing sodium nitroprusside as a nitric 
oxide generator and Greiss reagent as the detector. The method by Mayuret al., 2010 was followed to determine the 
scavenging activity of the samples. The samples and Vitamin C, positive control, were evaluated at concentrations ranging 
from 15.6 μg/ml to 2000 μg/ml. Sodium nitroprusside solution (0.01 M) was added to each well and incubated for 90 min, 
in light at room temperature. Subsequently, Griess reagent solution (1:1) was added to each well. For the negative color 
controls, distilled water was added instead of Griess reagent. The absorbance values of the samples were read using a multi-
well plate reader (BIO-TEK Power-Wave XS) set at a wavelength of 546 nm.  
 
Superoxide 
 
The method by Hyland et al., 1983 was used to determine the superoxide scavenging activity of the extracts, 
which, involves the use of alkaline DMSO to generate superoxide anions. In short, 100 µl of alkaline DMSO (5 mM 
NaOH) was added to all the wells of a 96-well microtiter plate. Serial dilutions were made to final concentrations which 
ranged from 3.90625 µg/ml – 500 µg/ml.  Next, 10 µl of NBT (10 mg NBT, 10 ml DMSO) was added to all the sample 
wells, while10 µl of DMSO was added to the color control wells. The absorbance of the plates were read using a multi-well 
plate reader (BIO-TEK Power-Wave XS) set at a wavelength of 560 nm.  
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Table 1: Traditional usage, the compounds isolated and biological activity tested of the plants selected for the study. 
Plant Plant part Traditional usage Anticancer 
activity 
reported 
Compounds isolated Reference 
Combretum 
molle R. Br. 
Ex G. Don 
Fruit  
 
 
Leaves 
 
 
 
 
Stem bark 
 
 
Roots 
 
 
 
 
Stem  
 
Leaves 
 
Leaves 
 
 
- 
 
- 
 
 
 
 
 
- 
 
 
- 
 
 
 
 
- 
Aid in childbirth. 
 
 
Wound dressing; antidiarrheal; 
anthelminthic; dropsy; chest 
complaints; and as an aid in 
childbirth. 
 
Angina and stomach problems. 
 
 
Wound dressing; hookworm; 
snakebites; leprosy; general body 
swellings; fever; stomach pains; 
constipation; sterility and abortion. 
 
- 
 
- 
 
- 
 
 
- 
 
- 
 
 
 
 
 
- 
 
 
- 
 
 
 
 
- 
- 
 
 
- 
 
 
 
 
- 
 
 
- 
 
 
 
 
Cytotoxicity 
 
Cytotoxicity 
 
Anti-
inflammatory 
 
- 
 
- 
 
 
 
 
 
- 
 
 
- 
 
 
 
 
- 
- 
 
 
- 
 
 
 
 
- 
 
 
- 
 
 
 
 
- 
 
- 
 
- 
 
 
Combretene A; Combretene B 
 
β-D-glucopyranosyl 2α,3β,6β-
trihydroxy-23-galloylolean-12-
en-28-oate; Combregenin; 
Arjungenin; Arjunglucoside I; 
Combreglucoside 
 
Sericoside; Arjunglucoside II;  
Punicalin 
 
Mollic acid; Mollic acid 3ß-O-
glucoside; Mollic acid 3ß-O-
arabinoside; Mollic acid 3ß-O-
Xyloside 
 
2,6-dihydroxy-2,3,6-
Watt & Breyer- 
Brandwijk, 1962 
 
Drummond & Coates- 
Palgrave, 1973; Haerdi, 1964; 
Kokwaro, 1976; Kerharo, 1974 
 
 
Kerharo, 1974; Watt 
& Breyer-Brandwijk, 1962 
 
Drummond & Coates-Palgrave, 1973; 
Watt & Breyer-Brandwijk, 1962; 
Kokwaro, 1976; Chhabra et al., 1989 
 
 
Fyhrquist et al. 2006 
 
Fyhrquist et al. 2006 
 
McGaw et al., 2001 
 
 
Bahar et al. 2004 
 
 
Kemvoufo et al. 2008 
 
 
 
 
Asres et al. 2001 
 
 
Pegel & Rogers, 1985 
 
 
 
 
Kovács et al. 2008 
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- 
 
 
 
 
 
 
 
 
 
- 
 
 
 
 
 
 
 
 
- 
 
trimethoxyphenanthrene; 
3,6-dihydroxy-2,4,7-
trimethoxyphenanthrene; 
2,6-dihydroxy-4,7-trimethoxy-
9,10-dihydrophenanthrene; 6,7-
dihydroxy-2,3,4-trimethoxy-
9,10-dihydrophenanthrene 
 
3,4-dihydroxy-4,5-
dimethoxybibenzyl 
 
 
 
 
 
 
 
 
Letcher et al. 1972 
 
Euclea crispa 
subsp. crispa 
(Thunb.) 
Gürke 
Roots 
 
Unspecifie
d parts 
 
Leaves 
 
 
 
Root bark 
Coughs 
 
Melanoma skin cancer 
 
 
- 
 
 
 
- 
- 
 
- 
 
 
- 
 
 
 
- 
- 
 
- 
 
 
Hyperoside; quercitrin; 
epicatechin; (+)- catechins; 
gallocatechin 
 
Lupeol; botulin; oleanolic acid 
Maroyi, 2013 
 
Gramham et al. 2000 
 
 
Pretorius et al. 2003 
 
 
 
Sibanda et al. 1992 
Sideroxylon 
inerme L. 
Bark 
 
 
 
Stem bark 
 
Roots 
 
 
Bark 
Skin hyperpigmentation; gall 
sickness in stock and red water in 
cattle 
 
Emetic 
 
Conjunctivitis; hernia; coughs; and 
paralysis 
 
Tonics to calves and goats 
Antioxidant 
activity; 
cytotoxicity 
 
- 
 
- 
 
 
- 
Epigallocatechin gallate; 
procyanidin B1. 
 
 
- 
 
- 
 
 
Cinnamic acid, kaempferol and 
leucanthocyanidins 
Momtaza et al. 2008;  
 
 
 
Chhabra et al. 1993 
 
Chhabra et al. 1993 
 
 
Hutchings et al., 1996 
Terminalia 
prunioides 
M.A. Lawson 
Unspecifie
d parts 
 
 
Fungal infections 
 
 
Skin diseases 
- 
 
 
- 
- 
 
 
- 
Fyhrquist, 2007 
 
 
Neuwinger, 1996 
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Statistical analysis 
 
A minimum of three experimental repeats were performed and each experiment was performed in triplicate to 
calculate the fifty percent inhibitory concentrations (IC50) of the samples. One-way Anova was used to evaluate the 
significant difference between the plant extracts and the positive controls for the cell proliferation and antioxidant assays. 
The IC50 values and one-way Anova analysis (Turkey method) were done by using GraphPad prism 4 software. 
 
Results and Discussion 
Plant extraction yield 
 
The ground plant material was extracted with ethanol and the percentage yield for each sample was calculated. 
The plant material weight and yield percentage results are given in table 2. The leaves extract from C. molle had the highest 
percentage yield (41%), whereas the C. molle fruit extract had the lowest percentage yield (6.5%). This finding could 
indicate high variability in the chemical composition of the different plant parts of the C. molle tree. E. crispa subsp. crispa 
had the second highest percentage yield (20%) followed by S. inerme (18%) and T. prunioides (14%). It would have been 
expected that the plant with the highest powdered material weight, E. crispa subsp. crispa, would also yield the highest 
percentage yield. Although ethanol is considered a more polar solvent, it does have the ability to extract non-polar 
compounds to a certain extent. Some of the plants might very well contain more non-polar compounds than polar 
compounds, which could denote why the weight of the powdered material is not directly proportional to the percentage 
yield among different plant species. 
 
Table 2: Weights and percentage yield results for the plant extracts. 
Plant Powdered weight (g) Extract weight (g) % Yield 
Combretum molle R. Br. Ex G. 
Don (leaves) 
22.4 9.2 41 
Combretum molle R. Br. Ex G. 
Don (fruits) 
25.6 1.7 6.5 
Euclea crispa subsp. crispa 
(Thunb.) Gürke (leaves and 
stems) 
43.3 8.6 20 
Sideroxylon inerme L. (leaves 
and stems) 
13.3 2.4 18 
Terminalia prunioides M.A. 
Lawson (leaves and stems) 
22.1 3.2 14 
 
Anti-proliferative activity 
 
The anti-proliferative activity of the plant extracts was evaluated against the A431, HCT-116. HCT-15; HeLa; 
MCF-7 and UCT-Mel 1 cancerous cell lines. In addition, the anti-proliferative activity of these samples was evaluated 
against a normal phenotype cell line, the HaCat cell line. The XTT colorimetric assay was used to evaluate the anti-
proliferative activity of the plant extracts against a range of cell lines. Mitochondrial dehydrogenase, an enzyme present in 
viable cells, reduces the yellow coloured water soluble form of XTT to an orange coloured insoluble formazan product 
(ATCC XTT Cell proliferation assay kit instruction manual, 2011). The results are given in table 3 as IC50 values, which 
denotes the concentration at which fifty percent of the cell proliferation and growth of the cells inhibited. Overall, the plant 
extracts showed the highest anti-proliferative activity on the A431 human epidermoid carcinoma cell line, with the C. molle 
fruit extract having activity with a low IC50 value of 23.2 µg/ml. The C. molle fruit extract has also shown to have 
noteworthy inhibitory effects on the growth and proliferation of some of the other cancerous cell lines including the HeLa, 
MCF-7 and UCT-Mel 1 cell lines with IC50 values found to be ranging from 48.7 to 51.3 µg/ml. Although these results 
show the in vitro potential, of the C. molle fruit extract to inhibit the growth and proliferation of cancerous cells, the low 
IC50 value of 45.9 µg/ml obtained for the normal HaCat cell line indicates that the extract might be more toxic towards the 
normal cells than those cancerous cells. 
The leaf and fruit extracts of C. molle showed growth inhibitory effects on the  HCT- 15 
human Duke's type C (lymph node metastasis) (Frederiksen et al., 2003), colorectal adenocarcinoma at low IC50 values of 
14.9 µg/ml and 24.2 µg/ml, respectively. This finding is curious when considering that no activity was found for the leaf 
and fruit extracts of C. molle on the HCT-116 which is also a human colorectal carcinoma cell line (Duke's type D- liver 
metastasis) (Ahmed et al., 2013). A study by Ahmed et al., 2013 showed that there are some gene mutation variant 
differences among the HCT-15 and HCT-116 cell lines. The HCT-15 cell line has gene mutation variants E545K and 
D549N for the PI3KCA gene, whereas the HCT-116 cell line showed a H4107R gene mutation variant. The HCT-15 cell 
line also had a S241F gene mutation variant for the TP53 gene while the HCT-116 cell line had no mutation variants for 
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this gene, displaying the wild type variant. The findings of the study showed that there are differences between cancerous 
cell lines even though the cell lines originate from the same type of tissue and disease. Therefore, it might be a possibility to 
find different activities of a particular sample on different cell lines originating from the same type of tissue and disease. 
 
Table 3: Effect of the extracts on the cell proliferation of various cell lines after 72h treatment. 
Treatment 
IC50 (µg/ml) ± SD 
 
A431 HaCat HCT-15 HCT-116 HeLa MCF-7 UCT-Mel 1 
Combretum molle 
R. Br. Ex G. Don 
Fruit extract 
23.2 ± 
0.8*** 
45.9 ± 
7.0*** 
24.2 ± 
0.028*** >200 
48.7 ± 
8.0*** 50.4 ± 0.6*** 51.3 ± 0.1*** 
Combretum molle 
R. Br. Ex G. Don 
Leaf extract 
68.6 ± 
4.0*** 
104.3 ± 
0.3*** 
14.9 ± 
0.054*** >200 >400 71.8 ± 1.0*** 
112.2 ± 
0.8*** 
Euclea crispa 
subsp. crispa 
(Thunb.) Gürke 
41.8 ± 
0.4*** 
167.2 ± 
4.0*** 
125.0 ± 
0.034*** 
148.5 ± 
8.9*** 
100.3 ± 
6.0*** 45.7 ± 7.0*** 70.9 ± 3.0*** 
Sideroxylon 
inerme L. 46.7 ± 2.0 119.2 ± 0.8 N/D 
137.2 ± 
3.0*** >400 93.1 ± 6.0*** 90.1 ± 3.0*** 
Terminalia 
prunioides M.A. 
Lawson 
158.6 ± 
0.05*** >400 N/D >200 >400 
140.6 ± 
7.0*** 
140.4 ± 
8.0*** 
Actinomycin Da 0.28 ± 0.018 
0.6 ± 1.8 × 
102 - - 
2.2 × 103 ± 
5.0 1.7 × 10
3 ± 5.0 2.7 × 10
2 ± 4 
× 104 
Oxaliplatinb   41 ± 4.2 15.40 ± 5.2     
**P-value < 0.01; ***P-value < 0.001 
A431: Human epidermoid carcinoma cell line 
HaCat: Human keratinocyte cell line 
HCT-116: Human colorectal carcinoma cell line 
HeLa: Human cervical adenocarcinoma cell line 
MCF-7: Human breast adenocarcinoma cell line 
UCT-Mel 1: Human pigmented malignant melanoma cell line 
IC50: Fifty percent inhibitory concentration 
SD: Standard deviation 
N/D: Not determined 
a: Positive control for the A431; HaCat; HeLa; MCF-7 and UCT-Mel 1 cell lines 
b: Positive control for the HCT-15 and HCT-116 cell line. 
 
The E. crispa extract and the S. inerme extract showed promising activity on the A431 cellline with IC50 values of 
41.8 µg/ml and 46.7 µg/ml, respectively. The E. crispa extract also showed anti-proliferative activity on the MCF-7 breast 
adenocarcinoma cell line with a low IC50 value of 45.7µg/ml. Given that the IC50 value found for the E. crispa extract on 
the HaCat cell line is high (167.2 µg/ml), it therefore indicates a much better safety margin than the C. molle fruit extract. 
As with the E. crispa extract, the S. inerme extract was found to have a relatively good safety margin due to its high IC50 
value of 119.2 µg/ml found against the HaCat cell line, when considering its activity on the A431 cell line. The C. molle 
leaf extract high to low anti-proliferative activity on the HCT-15, A431, MCF-7, HaCat and UCT-Mel 1 cell lines, while no 
activity was found against the HCT-116 or HeLa cell lines, up to the highest concentrations evaluated. A study by 
Fyhrquist et al., 2006 showed that a methanol leaf extract of C. molle had growth inhibitory activity on the T24 bladder 
cancer cell line with an IC50 value of 27.7 µg/ml. The research by Fyhrquist et al., 2006 also indicated that a methanol root 
extract of C. molle had similar activity to the methanolic leaf extract of C. molle on the T24 bladder cancer cell line, while 
only moderate growth inhibitory activity was found for both of the extracts against the HeLa and MCF-7 cell lines. 
 
Antioxidant activity 
 
The antioxidant potential of the extracts was determined by evaluating their capacity to scavenge the DPPH free 
radical, the nitric oxide reactive nitrogen species and the superoxide reactive oxygen species. The IC50 values are shown in 
table 4 and the dose-response curves of the extracts for the DPPH and nitric oxide antioxidant assays are given in figure 1 
and 2, respectively. All the plant extracts tested in this study showed scavenging activity for the DPPH radical at low 
concentrations and scavenging activity of the nitric oxide reactive nitrogen species and the superoxide reactive oxygen 
species at high concentrations. Since these three molecules are different from one another, it was expected that each plant 
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extract would react differently to each radical. The Terminalia prunioides (1.8 µg/ml)and Combretum molle (1.9 µg/ml)leaf 
extracts have shown exceptional DPPH radical scavenging activity as compared with the positive control, vitamin C (1.9 
µg/ml). A study by Masoko & Elof (2007) have shown that some of the extracts of Combretum molle and Terminalia 
prunioides do have DPPH scavenging activity. This study employed the use of a qualitative DPPH assay in which the leaf 
acetone extract showed strong DPPH scavenging activity where as the methanol extract of Terminalia prunioides and the 
acetone and methanol leaf extracts of Combretum molle has moderate DPPH scavenging activity. In the case of both plants, 
the hexane and dichloromethane leaf extracts showed no DPPH scavenging activity. The present study also showed that the 
ethanolic fruit extract of Combretum molle possess DPPH scavenging activity at a low IC50 value of 5.1 µg/ml.  
 
Table 4: The antioxidant activity of plant extracts for the DPPH, nitric oxide and superoxide scavenging assays. 
Sample IC50 (µg/ml) ± SD 
DPPH Nitric oxide Superoxide 
Combretum molle R. Br. 
Ex G. Don 
Fruit extract 
5.1±0.05*** 
  
180.3±1.2*** 
 
166.7±1.5*** 
 
Combretum molle R. Br. 
Ex G. Don 
Leaf extract 
1.9±0.006 
 
77.46±0.3*** 
 
 
124.4±3.9*** 
Euclea crispa subsp. crispa 
(Thunb.) Gürke 
2.5±0.02*** 
 
99.92±0.9*** 164.6±13.2*** 
Sideroxylon inerme L. 11.5±0.04*** 
 
131.5±0.4*** 115.6±15.6*** 
Terminalia prunioides 
M.A. Lawson 
1.8±0.007** 
 
86.13±0.2*** 135.9±10.5*** 
Vitamin Ca 
Quercetinb 
1.9±0.005 
 
62.74±0.9 
 
17.35±2.8 
**P-value < 0.01; ***P-value < 0.001 
DPPH: 2,2-diphenyl-1-picrylhydrazyl 
IC50: Fifty percent inhibitory concentration 
SD: Standard deviation 
a: Positive control for the DPPH and Nitric oxide scavenging assays 
b: Positive control for the Superoxide scavenging assay 
 
 
Figure 1: The dose-response curves of the inhibition of DPPH free radicals by the ethanolic plant extracts, C. molle 
(leaves); C. molle (fruit); E. crispa; S. inerme; and T. prunioides, and the positive control, Vitamin C. 
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Figure 2: The dose-response curves of the inhibition of Nitric oxide reactive nitric species by the ethanolic plant extracts,  
C. molle (leaves); C. molle (fruit); E. crispa; S. inerme; and T. prunioides, and the positive control, Vitamin C. 
 
The Euclea crispa extract also showed DPPH scavenging activity at an IC50 value of 2.5 µg/ml. Although this 
result compares well to a study by Shahid (2012) in which the IC50 values for DPPH scavenging activity from various 
extracts of Euclea crispa were shown to range from 0.84 µg/ml to 4.7 µg/ml, another study by Shahid (2012) indicated an 
IC50 value of 134.46 µg/ml for a hexane extract of Euclea crispa. The Sideroxylon inerme extract showed the activity at the 
highest concentration among the plant evaluated with anIC50value of 11.5 µg/ml, though a study conducted by Momtaz et 
al., 2008 obtained an IC50 value of 1.54 µg/ml for the methanolic bark extract of Sideroxylon inerme. Differences in results 
obtained between research studies could be attributed to the use of different plant parts and solvents. Although the extracts 
did not show scavenging activity in the nitric oxide and superoxide assays at low concentrations, the extracts did indicate to 
have scavenging potentials comparable to that of Vitamin C for the DPPH free radical. This activity found in this study 
suggests that further research on the antioxidant activity of these extracts should be conducted to provide a basis for their 
possible use as chemopreventive agents. 
 
 
Conclusion 
 
This study was conducted to evaluate the in vitro anti-cancer and chemopreventive potential of four indigenous 
South African plants commonly used in traditional medicine. The results indicated that three of the plant extracts, 
Combretum molle fruit extract; Euclea crispa subsp. crispa and Sideroxylon inerme, had anti-proliferative activity on the 
A431 cell line at low concentrations. The leaf and fruit extracts of Combretum molle were observed to have potent growth 
inhibitory activity on the HCT-15 cell line. The Euclea crispa subsp. crispa extract showed anti-proliferative activity on the 
MCF-7 cell line at a low concentration. All the extracts showed antioxidant potential by scavenging of the DPPH free 
radical. As such, this study provides the initial evidence of the potential of these extracts as anti-proliferative agents of 
cancerous cells and their possible chemopreventive activity via their antioxidant properties. 
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